CLINICAL_TRIALS
ClinicalTrials.gov record update
Coagulation Assays in the Critically Ill Patient: a New Approach Using the Thrombomodulin-modified Thrombin Generation Assay (TGA-TM)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04356144
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:15.050032+00:00
- Published At
- 2021-03-23T00:00:00+00:00
- Record Updated At
- 2021-03-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Disseminated Intravascular Coagulation", "Critical Illness", "Sars-CoV2", "Viral Infection", "Coagulation Disorder, Blood", "Covid19"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-03-23"- protocolSection.identificationModule.nctId
"NCT04356144"- protocolSection.identificationModule.officialTitle
"Coagulation Assays in the Critically Ill Patient: a New Approach Using the Thrombomodulin-modified Thrombin Generation Assay (TGA-TM)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.